Home »
Academic Articles »
C »
The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis
The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis
Katja Niesel
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Michael Schulz
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Julian Anthes
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Tijna Alekseeva
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Jadranka Macas
(Institute of Neurology (Edinger Institute), University Hospital, Goethe University)
Anna Salamero‐Boix
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Aylin Möckl
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Timm Oberwahrenbrock
(Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP))
Marco Lolies
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Stefan Stein
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Karl H Plate
(Institute of Neurology (Edinger Institute), University Hospital, Goethe University)
Yvonne Reiss
(Institute of Neurology (Edinger Institute), University Hospital, Goethe University)
Franz Rödel
(Frankfurt Cancer Institute (FCI), Goethe University Frankfurt)
Lisa Sevenich
(Institute for Tumor Biology and Experimental Therapy, Georg‐Speyer‐Haus)
Abstract The tumor microenvironment in brain metastases is characterized by high myeloid cell content associated with immune suppressive and cancer‐permissive functions. Moreover, brain metastases induce the recruitment of lymphocytes. Despite their presence, T‐cell‐directed therapies fail to elicit effective anti‐tumor immune responses. Here, we seek to evaluate the applicability of radio‐immunotherapy to modulate tumor immunity and overcome inhibitory effects that diminish anti‐cancer activity. Radiotherapy‐induced immune modulation resulted in an increase in cytotoxic T‐cell numbers and prevented the induction of lymphocyte‐mediated immune suppression. Radio‐immunotherapy led to significantly improved tumor control with prolonged median survival in experimental breast‐to‐brain metastasis. However, long‐term efficacy was not observed. Recurrent brain metastases showed accumulation of blood‐borne PD‐L1+ myeloid cells after radio‐immunotherapy indicating the establishment of an immune suppressive environment to counteract re‐activated T‐cell responses. This finding was further supported by transcriptional analyses indicating a crucial role for monocyte‐derived macrophages in mediating immune suppression and regulating T‐cell function. Therefore, selective targeting of immune suppressive functions of myeloid cells is expected to be critical for improved therapeutic efficacy of radio‐immunotherapy in brain metastases.
Katja Niesel, Michael Schulz, Julian Anthes, et al. (2021). "The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis". EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202013412